AU2014204873B2 - Polymyxins, compositions, methods of making and methods of use - Google Patents

Polymyxins, compositions, methods of making and methods of use Download PDF

Info

Publication number
AU2014204873B2
AU2014204873B2 AU2014204873A AU2014204873A AU2014204873B2 AU 2014204873 B2 AU2014204873 B2 AU 2014204873B2 AU 2014204873 A AU2014204873 A AU 2014204873A AU 2014204873 A AU2014204873 A AU 2014204873A AU 2014204873 B2 AU2014204873 B2 AU 2014204873B2
Authority
AU
Australia
Prior art keywords
uhplc
polymyxin
ch2ch
ch2ch2n
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2014204873A
Other languages
English (en)
Other versions
AU2014204873A1 (en
Inventor
Vidar Bjornstad
Solvi Gunnes
Torben Koch
Martin Mansson
Claes MELANDER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xellia Pharmaceuticals ApS
Original Assignee
Xellia Pharmaceuticals ApS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xellia Pharmaceuticals ApS filed Critical Xellia Pharmaceuticals ApS
Publication of AU2014204873A1 publication Critical patent/AU2014204873A1/en
Application granted granted Critical
Publication of AU2014204873B2 publication Critical patent/AU2014204873B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62Polymyxins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
AU2014204873A 2013-01-11 2014-01-09 Polymyxins, compositions, methods of making and methods of use Active AU2014204873B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361751341P 2013-01-11 2013-01-11
US61/751,341 2013-01-11
US201361904793P 2013-11-15 2013-11-15
US61/904,793 2013-11-15
PCT/EP2014/050320 WO2014108469A1 (en) 2013-01-11 2014-01-09 Polymyxins, compositions, methods of making and methods of use

Publications (2)

Publication Number Publication Date
AU2014204873A1 AU2014204873A1 (en) 2015-07-09
AU2014204873B2 true AU2014204873B2 (en) 2017-07-06

Family

ID=50101865

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2014204873A Active AU2014204873B2 (en) 2013-01-11 2014-01-09 Polymyxins, compositions, methods of making and methods of use

Country Status (20)

Country Link
US (1) US10640536B2 (enExample)
EP (1) EP2943503B1 (enExample)
JP (1) JP6316846B2 (enExample)
KR (1) KR20150107793A (enExample)
CN (1) CN104918951B (enExample)
AU (1) AU2014204873B2 (enExample)
BR (1) BR112015016548A2 (enExample)
CA (1) CA2895910C (enExample)
EA (1) EA027067B1 (enExample)
ES (1) ES2641017T3 (enExample)
HU (1) HUE034562T2 (enExample)
IL (1) IL239840A (enExample)
MX (1) MX360905B (enExample)
PT (1) PT2943503T (enExample)
RU (1) RU2015132569A (enExample)
SI (1) SI2943503T1 (enExample)
TW (1) TWI613219B (enExample)
UA (1) UA117673C2 (enExample)
WO (1) WO2014108469A1 (enExample)
ZA (1) ZA201504565B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA027067B1 (ru) 2013-01-11 2017-06-30 Кселлия Фармасьютикалз Апс Полимиксины, композиции, способы получения и способы применения
TW201522364A (zh) * 2013-06-07 2015-06-16 Xellia Pharmaceuticals Aps 黏菌素甲磺酸鈉(cms)之定性方法
JP2017523953A (ja) 2014-07-09 2017-08-24 クセリア ファーマシューティカルズ エーピーエスXellia Pharmaceuticals ApS 低置換度ポリミキシン及びその組成物
RS60874B1 (sr) 2014-10-03 2020-11-30 Xellia Pharmaceuticals Aps Kompozicije
SG11201702666SA (en) 2014-10-03 2017-04-27 Xellia Pharmaceuticals Aps Inhalation device
WO2016100578A2 (en) 2014-12-16 2016-06-23 Micurx Pharmaceuticals, Inc. Antimicrobial polymyxins for treatment of bacterial infections
FI126143B (en) * 2015-01-15 2016-07-15 Northern Antibiotics Oy Polymyxine derivative and its uses
AU2016331658B2 (en) * 2015-09-29 2021-04-01 Monash University Antimicrobial polymyxin derivative compounds
CN109996806B (zh) * 2016-12-09 2021-11-02 正大天晴药业集团股份有限公司 高效价的多黏菌素e2甲磺酸钠
CN115298198A (zh) 2020-01-21 2022-11-04 上海盟科药业股份有限公司 用于肾相关癌症靶向治疗的新型化合物和组合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1062895A (en) 1962-12-13 1967-03-22 Wellcome Found Sulphomethyl derivatives of polymxin
FR1586834A (enExample) 1968-02-12 1970-03-06
DE1906699A1 (de) 1968-02-12 1970-02-05 Pfizer Neue Polymyxinderivate und Verfahren zu deren Herstellung
EP0362370A1 (en) * 1988-04-07 1990-04-11 Edward Shanbrom Non-thrombogenic intravascular time release catheter
ATE202481T1 (de) 1996-11-15 2001-07-15 Pathogenesis Corp Reines, biologisch aktives colistin, seine bestandteile und eine colistin-zubereitung zur behandlung von entzündungen der atemwege
US5767068A (en) 1997-02-13 1998-06-16 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
ES2261735T3 (es) 2001-05-18 2006-11-16 Chiron Corporation Sistema para la administracion de una formulacion de tobramicina.
US20040022740A1 (en) 2001-07-10 2004-02-05 Baker William R. Macrolide formulations for inhalation and methods of treatment of endobronchial infections
EP1940859A1 (en) * 2005-10-28 2008-07-09 Arch Pharmalabs Limited An improved process for preparation of gemcitabine hydrochloride
WO2008025560A1 (en) 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
US20080066739A1 (en) 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation
WO2012168820A1 (en) 2011-06-08 2012-12-13 Pfizer Inc. Polymyxin derivatives useful as antibacterial agents
EA027067B1 (ru) 2013-01-11 2017-06-30 Кселлия Фармасьютикалз Апс Полимиксины, композиции, способы получения и способы применения
TW201522364A (zh) 2013-06-07 2015-06-16 Xellia Pharmaceuticals Aps 黏菌素甲磺酸鈉(cms)之定性方法
JP2017523953A (ja) 2014-07-09 2017-08-24 クセリア ファーマシューティカルズ エーピーエスXellia Pharmaceuticals ApS 低置換度ポリミキシン及びその組成物
RS60874B1 (sr) 2014-10-03 2020-11-30 Xellia Pharmaceuticals Aps Kompozicije

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Bergen, Phillip J., et al. "Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa." Antimicrobial agents and chemotherapy 50.6 (2006): 1953-1958. *

Also Published As

Publication number Publication date
KR20150107793A (ko) 2015-09-23
EP2943503A1 (en) 2015-11-18
RU2015132569A (ru) 2017-02-14
CN104918951A (zh) 2015-09-16
ES2641017T3 (es) 2017-11-07
JP2016505007A (ja) 2016-02-18
SI2943503T1 (sl) 2017-11-30
CA2895910A1 (en) 2014-07-17
US10640536B2 (en) 2020-05-05
MX360905B (es) 2018-11-21
TW201429995A (zh) 2014-08-01
US20160002296A1 (en) 2016-01-07
CA2895910C (en) 2021-12-21
UA117673C2 (uk) 2018-09-10
AU2014204873A1 (en) 2015-07-09
MX2015008878A (es) 2015-10-30
IL239840A (en) 2017-09-28
IL239840A0 (en) 2015-08-31
EA201591280A1 (ru) 2015-12-30
HUE034562T2 (en) 2018-03-28
JP6316846B2 (ja) 2018-04-25
EA027067B1 (ru) 2017-06-30
EP2943503B1 (en) 2017-08-23
CN104918951B (zh) 2018-03-30
TWI613219B (zh) 2018-02-01
WO2014108469A1 (en) 2014-07-17
ZA201504565B (en) 2016-11-30
PT2943503T (pt) 2017-09-28
BR112015016548A2 (pt) 2017-07-11

Similar Documents

Publication Publication Date Title
AU2014204873B2 (en) Polymyxins, compositions, methods of making and methods of use
USRE48335E1 (en) Polymyxin derivatives as antimicrobial compounds
WO2010075416A1 (en) Antibiotic compositions for the treatment of gram negative infections
CN1964736B (zh) 治疗细菌感染的达巴万星组合物
AU2016331658A1 (en) Antimicrobial polymyxin derivative compounds
CA2949328C (en) Low substituted polymyxins and compositions thereof
EP2542265A2 (en) Guanidinylated aminoglycoside -lipid conjugates
US8410044B2 (en) Bacitracin antibiotics

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)